A Pittsburgh medical practice has been ordered to pay a fine following a guilty plea involving the purchase of unapproved, foreign pharmaceuticals.
Jan C. Seski, M.D. & Associates, an oncology practice with offices in Oakland and West Mifflin, pleaded guilty Thursday in federal court in California to a criminal charge of having caused the introduction of an unapproved drug into interstate commerce. The practice was ordered to pay a $100,000 fine and to place advertisements in two medical journals, warning of the dangers of unapproved drugs.
The guilty plea was announced by U.S. Attorney Laura E. Duffy of the Southern District of California in San Diego.
In pleading guilty before U.S. Magistrate Judge Karen S. Crawford, the medical practice admitted that between Dec. 4, 2008, and May 25, 2011, the practice ordered $973,795 worth of foreign versions of the oncology drugs Eloxatin7, Gemzar7 and Taxotere7 from GlobalRxStore.com and had them shipped through Oberlin Medical Supply of San Diego.